Expression and regulation of CCL15 by human airway smooth muscle cells

Clinical and Experimental Allergy

Volumn 42, Issue 1, 2012, Pages 85-94

  Joubert, P ^a   Lajoie Kadoch, S ^a   Wellemans, V ^b   Letuve S ^c   Tulic, M K ^d   Halayko, A J ^e   Hamid, Q ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c INSERM   (France)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Airway smooth muscle cells; Asthma; Chemokine; Cytokines; Leukotactin 1

Indexed keywords

1 [5 HYDROXY 2 (2 THIENYL) 4 QUINAZOLINYLAMINO] 3 METHYL 2,5 PYRROLEDIONE; CCL15 CHEMOKINE; CHEMOKINE; DEXAMETHASONE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 13; INTERLEUKIN 4; MESSENGER RNA; MITHRAMYCIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AIRWAY SMOOTH MUSCLE CELL; ARTICLE; ASTHMA; BREATHING MUSCLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; UPREGULATION;

ADULT; ASTHMA; BIOPSY; BRONCHI; CHEMOKINES, CC; FEMALE; HUMANS; INTERFERON-GAMMA; MACROPHAGE INFLAMMATORY PROTEINS; MALE; MIDDLE AGED; MYOCYTES, SMOOTH MUSCLE; REAL-TIME POLYMERASE CHAIN REACTION; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84655162093     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2011.03894.x     Document Type: Article

References (39)

1. Knox AJ, Pang L, Johnson S, Hamad A. Airway smooth muscle function in asthma. Clin Exp Allergy 2000; 30:606-14.
2. Panettieri RA Jr. Airway smooth muscle: an immunomodulatory cell. J Allergy Clin Immunol 2002; 110(6 Suppl.):S269-74.
3. Pardigol A, Forssmann U, Zucht HD et al. HCC-2, a human chemokine: gene structure, expression pattern, and biological activity. Proc Natl Acad Sci USA 1998; 95:6308-13.
4. Wang W, Bacon KB, Oldham ER, Schall TJ. Molecular cloning and functional characterization of human MIP-1 delta, a new C-C chemokine related to mouse CCF-18 and C10. J Clin Immunol 1998; 18:214-22.
5. Forssmann U, Magert HJ, Adermann K, Escher SE, Forssmann WG. Hemofiltrate CC chemokines with unique biochemical properties: HCC-1/CCL14a and HCC-2/CCL15. J Leukoc Biol 2001; 70:357-66.
6. Lee JS, Kim IS. Leukotactin-1/CCL15 induces cell migration and differentiation of human eosinophilic leukemia EoL-1 cells through PKC delta activation. Mol Biol Rep 2010; 37:2149-56.
7. Hwang J, Kim CW, Son KN et al. Angiogenic activity of human CC chemokine CCL15 in vitro and in vivo. FEBS Lett 2004; 570:47-51.
8. Coulin F, Power CA, Alouani S et al. Characterisation of macrophage inflammatory protein-5/human CC cytokine-2, a member of the macrophage-inflammatory-protein family of chemokines. Eur J Biochem 1997; 248:507-15.
9. Yu R, Kim CS, Kawada T et al. Involvement of leukotactin-1, a novel CC chemokine, in human atherosclerosis. Atherosclerosis 2004; 174:35-42.
10. Hamann KJ, Vieira JE, Halayko AJ et al. Fas cross-linking induces apoptosis in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2000; 278:L618-24.
11. Naureckas ET, Ndukwu IM, Halayko AJ, Maxwell C, Hershenson MB, Solway J. Bronchoalveolar lavage fluid from asthmatic subjects is mitogenic for human airway smooth muscle. Am J Respir Crit Care Med 1999; 160:2062-6.
12. Letuve S, Lajoie-Kadoch S, Audusseau S et al. IL-17E upregulates the expression of proinflammatory cytokines in lung fibroblasts [Research Support, Non-U.S. Gov't]. J Allergy Clin Immunol 2006; 117:590-6.
13. Cossette C, Patel P, Anumolu JR et al. Human neutrophils convert the sebum-derived polyunsaturated fatty acid Sebaleic acid to a potent granulocyte chemoattractant [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.]. J Biol Chem. 2008; 283:11234-43.
14. Druilhe A, Letuve S, Pretolani M. Glucocorticoid-induced apoptosis in human eosinophils: mechanisms of action. Apoptosis. 2003; 8:481-95.
15. Hajoui O, Janani R, Tulic M et al. Synthesis of IL-13 by human B lymphocytes: regulation and role in IgE production. J Allergy Clin Immunol 2004; 114:657-63.
16. Lajoie-Kadoch S, Joubert P, Letuve S et al. TNF-alpha and IFN-gamma inversely modulate expression of the IL-17E receptor in airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2006; 290:L1238-46.
17. Shin YH, Shim JJ, Hur MW, Kang CJ, Kim J. Involvement of two NF-kappaB binding sites in PMA-induced expression of the human leukotactin-1/CCL15 gene in U937 monocytoid cells. Mol Cells 2004; 17:316-21.
18. Gouwy M, Struyf S, Proost P, Van Damme J. Synergy in cytokine and chemokine networks amplifies the inflammatory response. Cytokine Growth Factor Rev 2005; 16:561-80.
19. Cohn L, Elias JA, Chupp GL. Asthma: mechanisms of disease persistence and progression. Annu Rev Immunol 2004; 22:789-815.
20. Cho SH, Stanciu LA, Holgate ST, Johnston SL. Increased interleukin-4, interleukin-5, and interferon-gamma in airway CD4+ and CD8+ T cells in atopic asthma. Am J Respir Crit Care Med 2005; 171:224-30.
21. Birkisson IF, Halapi E, Bjornsdottir US et al. Genetic approaches to assessing evidence for a T helper type 1 cytokine defect in adult asthma. Am J Respir Crit Care Med 2004; 169:1007-13.
22. Magnan AO, Mely LG, Camilla CA et al. Assessment of the Th1/Th2 paradigm in whole blood in atopy and asthma. Increased IFN-gamma-producing CD8(+) T cells in asthma. Am J Respir Crit Care Med 2000; 161:1790-6.
23. ten Hacken NH, Oosterhoff Y, Kauffman HF et al. Elevated serum interferon-gamma in atopic asthma correlates with increased airways responsiveness and circadian peak expiratory flow variation [Research Support, Non-U.S. Gov't]. Eur Respir J 1998; 11:312-6.
24. Cembrzynska-Nowak M, Szklarz E, Inglot AD, Teodorczyk-Injeyan JA. Elevated release of tumor necrosis factor-alpha and interferon-gamma by bronchoalveolar leukocytes from patients with bronchial asthma. Am Rev Respir Dis 1993; 147:291-5.
25. Bradding P, Roberts JA, Britten KM et al. Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol 1994; 10:471-80.
26. Paludan SR. Synergistic action of pro-inflammatory agents: cellular and molecular aspects. J Leukoc Biol 2000; 67:18-25.
27. Neish AS, Read MA, Thanos D, Pine R, Maniatis T, Collins T. Endothelial interferon regulatory factor 1 cooperates with NF-kappa B as a transcriptional activator of vascular cell adhesion molecule 1. Mol Cell Biol 1995; 15:2558-69.
28. Drew PD, Franzoso G, Becker KG et al. NF kappa B and interferon regulatory factor 1 physically interact and synergistically induce major histocompatibility class I gene expression. J Interferon Cytokine Res 1995; 15:1037-45.
29. Lee AH, Hong JH, Seo YS. Tumour necrosis factor-alpha and interferon-gamma synergistically activate the RANTES promoter through nuclear factor kappaB and interferon regulatory factor 1 (IRF-1) transcription factors. Biochem J 2000; 350(Pt 1):131-8.
30. Shin YH, Son KN, Lee GW, Kwon BS, Kim J. Transcriptional regulation of human CC chemokine CCL15 gene by NF-kappaB and AP-1 elements in PMA-stimulated U937 monocytoid cells. Biochim Biophys Acta 2005; 1732:38-42.
31. Clarke DL, Clifford RL, Jindarat S et al. TNFalpha and IFNgamma synergistically enhance transcriptional activation of CXCL10 in human airway smooth muscle cells via STAT-1, NF-kappaB, and the transcriptional coactivator CREB-binding protein. J Biol Chem 2010; 285:29101-10.
32. Reichardt HM, Kaestner KH, Tuckermann J et al. DNA binding of the glucocorticoid receptor is not essential for survival. Cell 1998; 93:531-41.
33. Reichardt HM, Tuckermann JP, Gottlicher M et al. Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor. EMBO J 2001; 20:7168-73.
34. Tuckermann JP, Reichardt HM, Arribas R, Richter KH, Schutz G, Angel P. The DNA binding-independent function of the glucocorticoid receptor mediates repression of AP-1-dependent genes in skin. J Cell Biol 1999; 147:1365-70.
35. Ahn SY, Cho CH, Park KG et al. Tumor necrosis factor-alpha induces fractalkine expression preferentially in arterial endothelial cells and mithramycin A suppresses TNF-alpha-induced fractalkine expression. Am J Pathol 2004; 164:1663-72.
36. Jiang Y, Beller DI, Frendl G, Graves DT. Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes. J Immunol 1992; 148:2423-8.
37. Rossi D, Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 2000; 18:217-42.
38. Richter R, Forssmann U, Henschler R, Escher S, Frimpong-Boateng A, Forssmann WG. Increase of expression and activation of chemokine CCL15 in chronic renal failure. Biochem Biophys Res Commun 2006; 345:1504-12.
39. Berry M, Brightling C, Pavord I, Wardlaw A. TNF-alpha in asthma. Curr Opin Pharmacol 2007; 7:279-82.